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Abstract
Introduction Tissue engineering provides an alternative modality allowing
for decreased morbidity of donor site grafting and decreased rejection of less
compatible alloplastic tissues.
Methods Using image-based design and computer software, a precisely
sized and shaped scaffold for osseous tissue regeneration can be created
via selective laser sintering. Polycaprolactone has been used to create a
condylar ramus unit (CRU) scaffold for application in temporomandibular
joint reconstruction in a Yucatan minipig animal model. Following sacrifice,
micro-computed tomography and histology was used to demonstrate the
efficacy of this particular scaffold design.
Results A proof-of-concept surgery has demonstrated cartilaginous tissue
regeneration along the articulating surface with exuberant osseous tissue
formation. Bone volumes and tissue mineral density at both the 1 and
3 month time points demonstrated significant new bone growth interior and
exterior to the scaffold.
Conclusion Computationally designed scaffolds can support masticatory
function in a large animal model as well as both osseous and cartilage
regeneration. Our group is continuing to evaluate multiple implant designs
in both young and mature Yucatan minipig animals. Copyright  2007 John
Wiley & Sons, Ltd.
Keywords Tissue Engineering; Scaffold; Polycaprolactone; Temporomandibular
joint; image based design; bone regeneration
Introduction
Surgeons are forever searching for improved techniques for reconstruc-
tion. Surgically removed pathology, traumatic lesions, degenerative changes
and infectious conditions can all result in significant soft- and hard-
tissue defects. Over the years, autogenous bone has remained the gold
standard for maxillofacial reconstruction (1–5). Distraction osteogenesis
has also been attempted but is inconvenient, due to a longer treatment
time, failure of the device and need for further procedures (6–8). Pre-
pared allogeneic tissues can also be used; however, patients run the
risk of disease transmission, inflammation and ultimately rejection (9).
More recently, biologically inert alloplastic materials offer a reasonable
alternative (2,4); however, these materials are not bioresorbable and
pose continued risks of inflammation and possible infection (2,4,10,11).
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Tissue engineering (TE) is continuing to evolve,
offering new techniques and biocompatible materials to
recapitulate the facial skeleton. An ideal tissue-engineered
product would achieve a number of goals to be considered
effective (12–15). First, it must regenerate complex three-
dimensional (3D) anatomical defects, while possessing
mechanical properties similar to the native structures,
allowing for function and possible immediate load
bearing, while at the same time preventing stress shielding
through material tissue stiffness mismatch. Second, the
materials used must be biocompatible and, ideally,
bioresorbable, to avoid significant tissue response by
either rejection through an immunological response or
foreign body reaction through an inflammatory response.
Third, it must contain continuous internal porosity
for proper tissue formation, and nutrient and waste
exchange, while discouraging excess tissue growth and
harmful fibrous tissue ingrowth. Last, it should encourage
appropriate cell differentiation through either soluble
or insoluble factor signalling and/or allow for delivery
of pluripotent cell types, such as cells derived from
patient bone marrow (12–16). These soluble or insoluble
signals are variable, depending upon the application,
but may include growth factors and other proteins,
gene therapy vectors, surface modifications affecting
cell attachment and differentiation, and the physical
properties of the scaffold microstructure itself (mechano-
signalling, micropatterning) (12,17). By providing a
construct to fill the defect, cells from surrounding tissues
or delivered cells grow within an enriched environment,
the regenerated tissues remodel and the scaffold itself
slowly degrades. An optimal degradation pattern allows
for maturation of regenerated tissues to support the
mechanical load at the same rate that the scaffold gives




Recently, the use of computed tomography (CT) and
magnetic resonance imaging (MRI) has extended beyond
the diagnosis of disease processes to their use as a dataset
for TE applications (12,14,20–22). One clear advantage
of using these datasets is to create a 3D surgical model
(23,24). More recently they have been applied to defining
specific anatomical geometries for TE scaffold creation.
In regions of defects or abnormal anatomy, a template
can be produced using a mirrored image of the
contralateral side to recreate normal anatomy. If the
desired outcome is to fill in a defect space precisely,
a template can be created using image-processing
techniques to select and define the defect area from
the CT/MRI data. Scaffolds can be designed from
these imaging templates by adjusting grey-scale density
distribution within a voxel dataset. A structured voxel
dataset is a regular cubic grid containing volume elements
called voxels. These voxels have a grey-scale density range
of 0–255 when using an eight-bit representation of data.
On the global anatomical level, a mapping dataset can be
created by defining a threshold density level between 0
and 255, where any voxels having density above the
threshold level are considered to be material in the
scaffold, while voxels below the threshold are considered
to be void (14,21,22,25).
Once the mapping dataset is created at the global
anatomical level, a porous architecture database is
designed on a microstructural level. Criteria and opti-
mization algorithms for designing the porous architecture
have been detailed elsewhere (14,21,25–27). A variety
of individual porous architecture designs can be used
within a single scaffold by creating local image databases
(28). For example, these local image databases can be
combined to produce a heterogeneous internal structure
within the scaffold, allowing for variations in porous
microstructure that may create region-specific changes
in properties, such as modulus, permeability and pore
shape (14,21,25,29). In general, the porous architecture
is designed to give desired mechanical and mass trans-
port properties, taking into account the base properties
of the scaffold biomaterial. By providing high porosity to
increase biofactor delivery, one runs the risk of reducing
strength (elastic modulus and yield strength) of the scaf-
fold. The ideal is to design a scaffold, paying attention
to the intrinsic properties of the biodegradable material
to be used, that provides a high porosity for nutrient and
metabolic waste exchange while being able to withstand
mechanical load and function in the desired anatomical
location (14,16,19,21,25,26,28,29).
Scaffold fabrication
Scaffolds themselves have been created by a variety of
methods, using a variety of biomaterials, including poly-
mers, ceramics and composites. Biodegradable polymers
include polylactic acid, polyglycolic acid, polypropylene
fumarate and polycaprolactone (16,30–38). Ceramics
such as hydroxyapatite and tricalcium phosphate are
used but degrade minimally over time (6,14,39). Com-
posite scaffolds may include any combination of poly-
mers, ceramics, metals and biofactors, and attempt
to maximize tissue regeneration within the scaffold
(12,16,17,19,29,40–46).
Conventional fabrication methods include salt leaching,
solvent casting, the use of fibre-based fabrics, thermal
phase separation, melt moulding, membrane lamination,
templating, fluid-gassing and emulsion freeze-drying
(47,48). Major fallbacks include the use of toxic
organic solvents during the manufacturing process, less
predictable external and internal geometries, and extreme
technique sensitivity. In order to circumvent these
limitations, the use of solid free-form fabrication (SFF) in
tissue engineering was established. SFF is a technique that
allows the precise fabrication of complex 3D anatomical
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scaffolds created by computer-generated image-based
design techniques, using a layer-by-layer manufacturing
approach (12,47,49–51). Techniques include fused
deposition modelling, 3D printing, stereolithography, ink-
jet printing and selective laser sintering (SLS).
SLS uses a laser to provide thermal energy to
sinter particles together without causing degradation to
the underlying chemical composition. Layer by layer,
sequential films of powder are deposited onto the bed,
while the laser and radiant heaters selectively coalesce
particles of powder through the application of thermal
energy, causing an overall release of surface free energy
(Figure 1). The subsequent layer will fuse with the
underlying layer within the bed of surrounding loose
powder.
Our primary focus has been evaluating SLS fabricated
polycaprolactone (PCL) scaffolds for TE applications.
PCL is a well-characterized, biocompatible, bioresorbable
polymer that has been approved for human use
by the United States Food and Drug Administration
(www.fda.gov). It possesses a number of desired
characteristics for use in TE. It has been documented
as having an approximate in vivo degradation time
of approximately 2 years (52). PCL powder marketed
under CAPA 6501 (Solvay Caprolactones, Warrington,
UK) possesses a semi-crystalline structure, with 99% of
the particles measuring less than 100 µm. Its melting
point is 58–60 ◦C, with a decomposition temperature of
350 ◦C. It can also be processed with other polymers,
such as polylactic and polyglycolic acids (52). In solid
cylindrical form, PCL created using SLS possesses a
compressive modulus of 122 MPa and a compressive
strength of 11.7 MPa. These values are on the lower end
of human mandibular trabecular bone in the region of
the condyle. SLS scaffolds with 50% porosity demonstrate
a compressive modulus of 55 MPa and a compressive
strength of 2.3 MPa (12,53).
Figure 1. Solid free-form fabrication – selective laser sintering
process schematic
Specifically, we have investigated the manufacture of a
computer-designed scaffold for temporomandibular joint
replacement. Using a Yucatan minipig animal model,
we have created a condylar ramus unit (CRU) scaffold.
Condylectomies were performed in both young and
mature age groups, although we are now focusing on
the mature animal model, as there exists a restricted
growth potential that will more appropriately relate to
human populations.
Methods
The first step in creating the CRU scaffold was segmenta-
tion of the condyle shape from a representative CT scan of
both a young and a mature minipig mandible. The image
dataset was read using a variety of commercial software,
including ANALYSE (www.analysedirect.com), Interac-
tive Data Language (IDL; www.ittvis.com) and MATLAB
(www.mathworks.com). A means to surgically fix the
scaffold to the ramus was added by creating a collar with
screw holes that would fit around the mandibular ramus
(post-condylectomy). The collar was created by perform-
ing image dilatation of the ramus in the inferior–superior
direction (Figure 2A). The dilatation essentially expands
the structure outward from the ramus. Finally, the condy-
lar head region of the scaffold image is created with two
different density values to allow mapping of a designed
porous architecture (Figure 2B).
For the current application (prototype surgery), a
shell configuration for replacement of the condylar head
was developed, in order to evaluate overall growth
potential of osseous and cartilaginous tissues within
the confines of a biodegradable scaffold. In additional
surgeries, we are comparing the use of orthogonal
Figure 2. Example of image-based design for condyle scaffold
from CT scan. (A) Dilatation of original segmented condylar
head slice to create scaffold fixation collar. (B) Slice of designed
image data showing condylar head mapping data, original ramus
and designed screwholes
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Figure 3. Example of image-based design procedure for mandibular condyle scaffold. (A) CT scan of Yucatan minipig condyle used
to design external anatomical shape and surgical fixation. (B–D) Porous architecture databases based on geometrical equations
for bone and cartilage region. (E) Final integrated image design of mandibular condyle scaffold with external anatomical shape,
surgical fixation, and interior designed porous architecture. (F) Mandibular condyle scaffold architecture design fabricated from
polycaprolactone, a degradable biopolymer. (G) Final image design of mandibular condyle scaffold, demonstrating anatomical
shape, surgical fixation and shell condylar region. (H) Mandibular condyle scaffold shell design fabricated from polycaprolactone
channel architecture with a spherical void in an attempt
to enhance cartilage matrix formation. Results of these
studies are pending. Figure 3 illustrates the entire image-
based scaffold design procedure from CT scan through to
final fabricated scaffold. Figure 4 demonstrates a higher-
resolution image of the scaffold design, with orthogonal
strut architecture engineered to the specific dimensions
of the condylar head and the cross-section of the dilated
ramus sleeve.
Using PCL (CAPA 6501), a CRU scaffold for a young
Yucatan minipig (Lone Star Swine, Seguin, TX, USA)
was fabricated with SLS. Our SLS system uses a low-
power CO2 laser (λ10.6 µm, continuous wave, power
<10 W) focused to a 450 µm spot (Sinterstation 2000, a
commercial SLS machine; 3D Systems Inc., Valencia, CA,
USA) (9,54).
Figure 4. High-resolution depictions of image-based designed
CRU. (A) Precisely engineered orthogonal strut architecture
replacing condylar head of minipig mandible. (B) Dilated
mandibular ramus sleeve in cross-section (yellow)
With approval of the University of Michigan animal
ethics committee (UCUCA; www.ucuca.umich.edu), our
prototype surgery involved placement of a shell CRU
scaffold into five young animals (aged 6–8 months).
The animals were anaesthetized and a horizontal
condylectomy was performed, as demonstrated in
Figure 5. The condylar head of the CRU was then
packed with iliac crest bone marrow harvested from each
animal, and the fitted CRU scaffold sleeve was inserted
over the mandibular ramus. The condylar head closely
reapproximated the vertical dimension and volume of
the condylectomy segment and provided a new articular
surface for the minipig to function with. The CRU
was then secured using miniplates and screws (KLS
Martin, Jacksonville, FL, USA; Figure 6). The contralateral
temporomandibular joint (TMJ) was left intact as a
control.
Following a postoperative period of either 1 or
3 months, the animals were sacrificed. The condyles and
their opposing articular eminence of both the treated and
control sides were sectioned en bloc (articular eminence,
articular disc, CRU scaffold and surrounding mandible)
for further evaluation.
Micro-CT
The harvested specimens were imaged in water using
micro-computed tomography (micro-CT; GE Healthcare
Explore MS-130 scanner with a 20–130 kVp, 0–500 mA,
micro-focus cone beam X-ray source: London, ON,
Canada; www.gehealthcare.com). The system settings
were 75 kVp and 75 mA, and data were acquired with an
isotropic voxel size of 45 µm. Houndsfield unit calibration
was performed with a phantom containing water, air
and cortical bone mimic. Using a Feldkamp cone beam
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Figure 5. Horizontal condylectomy of mandibular condyle
reconstruction algorithm (55), a 3D representation of
the material scanned was used to evaluate for growth
of new bone, both within and external to the scaffold.
The data were reorientated in Microview 2.1.2 software
(www.microview.sourceforge.net) with the Visualization
Plus plug-in (GE Healthcare, London, ON, Canada) to
identify the ostectomy plane relative to bony landmarks
and fixation screw positions. Using a uniform threshold
value, new bone volume was determined. The isolation
of desired areas was achieved by defining a specified
region of interest (ROI), using the Advanced ROI plug-
in and the spline tool. Tissue mineral density and
content, indicators of the quality of newly formed osseous
tissue, were calculated for each ROI. Condylectomy
pieces above the sectioned mandible at the time of
initial surgery, from a representative group of young
minipigs, were also subjected to micro-CT for bone volume
quantification.
Histology
The specimens were then decalcified, paraffin-embedded
and sectioned (10 µm)for histological analysis of the
regenerated joint structure and surface. Histological
staining was performed using haematoxylin and eosin
(H&E) to evaluate bone regeneration and architecture
within and external to the scaffold. Fast green/safranin
O stain was utilized for demonstration of cartilagi-
nous tissue formation, with focus along the joint sur-
face.
Table 1. Bone volume and tissue mineral density of condylec-
tomy control segments from six young Yucatan minipigs
Controls (six young
minipigs) BV (mm3) TMD (mg/cc)
Ave 1524.2 477.3
SD 337.8 17.1
BV, bone volume; TMD, tissue mineral density
Figure 6. (A) Iliac crest bone marrow packed into scaffold condylar head. (B) Scaffold well adapted to native mandible. (C) Scaffold
secured to ramus
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Table 2. Bone volume and tissue mineral density regenerated above the condylectomy line at both 1 and 3 month time points
Total new bone
New bone external to
implant
New bone internal to
implant
BV (mm3) TMD (mg/cc) BV (mm3) TMD (mg/cc) BV (mm3) TMD (mg/cc)
Shell, 1 month Pig 1 1221.81 549.5 829.2 589.0 392.9 466.0
Pig 2 1425.36 462.8 1167.5 463.4 541.0 460.4
Ave 1323.6 506.1 998.4 526.2 325.3 463.2
SD 143.9 61.2 239.3 88.8 95.5 4.0
Shell, 3 months Pig 3 4634.32 588.4 3347.1 568.6 1287.2 639.7
Pig 4 5455.60 572.6 4409.8 565.9 1045.8 600.5
Ave 5045.0 580.5 3878.5 567.3 1166.5 620.1
SD 580.7 11.2 751.5 1.9 170.8 27.7
BV, bone volume; TMD, tissue mineral density.
Results
All five of the animals returned to full masticatory
function. Micro-CT data was obtained for condylectomy
segments of six Yucatan minipigs for control (Table 1).
Figure 7. Total bone volume of treatment groups compared to
controls
Micro-CT data of bone volume and tissue mineral den-
sity demonstrated evidence of new bone growth within
the implanted scaffold in four of the five animals
(Table 2). One animal was noted to have an infec-
tion that was treated prior to sacrifice. Although bone
was formed outside the scaffold, this young minipig did
not regenerate mineralized tissues within the scaffold,
Figure 8. Tissue mineral density of control group vs. treatment
groups
Figure 9. 3D micro-CT images. (A) Exuberant bone tissue formation adjacent to native zygomatic arch (arrow) and coronoid
process (arrowhead). (B) large amount of bone tissue formed external to scaffold (void highlighted by arrow)
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Figure 10. 3D micro-CT volume dataset image. Bone formation
above condylectomy cut is depicted within scaffold (orange) and
external to scaffold (yellow)
therefore the results are not included in the analysis.
At the 1 month time point, total bone volume (treat-
ment group, n = 2, 1323.6 ± 143.9 mm3; control group,
n = 6, 1524.2 ± 337.8 mm3) and tissue mineral density
(treatment group, 506.1 ± 61.2 mg/cc; control group,
477.3 ± 17.1 mg/cc) were comparable to controls. At the
3 month time point, total bone volume (treatment group,
n = 2, 5045.0 ± 580.7 mm3) and tissue mineral density
(treatment group, n = 2, 580.5 ± 11.2) were substantially
increased. It was notable that there was a large amount
of bone evident external to the confines of the scaffold
in both the 1 and 3 month treatment groups. The bone
volume within the scaffold closely reapproximated the
control condylectomy segments at 3 months (Figure 7).
Overall tissue mineral density also closely approximated
controls in both treatment groups (Figure 8). Figures 9
and 10 demonstrate 3D images of bone growth. Histolog-
ical analysis demonstrates normal osseous architecture
both internal and external to the scaffold compared to
contralateral control temporomandibular joints in the
same animal (Figures 11, 12). Cartilaginous tissue for-
mation is clearly evident along the articular surface in
the young animals at both the 1 and 3 month time points
(Figure 13).
Discussion
The surgeries described show promising results for the
application of tissue engineering in temporomandibular
reconstruction. Using bone volume quantification from
the micro-CT datasets, the young animal model clearly
demonstrated an exuberant amount of osseous tissue
using a biodegradable tissue-engineered scaffold, possibly
due to its innate healing response. Along with the
formation of osseous tissues, histology displayed the
production of cartilaginous tissues on the articular
surfaces of the regenerated condyles.
Image-based design techniques provide two important
advantages for scaffold design (14,21). First, image-
based design techniques are directly compatible with
Figure 11. Normal temporomandibular joints in the young Yucatan minipig. Contralateral control joints with (A) H&E, (B) safranin
O/fast green stains
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Figure 12. H&E-stained sagittal section of treatment group.
Scaffold is a void depicted by arrows. Exuberant bone tissue
with normal architecture exists external to scaffold. Temporo-
mandibular disc relationship is maintained (arrowheads)
CT and MRI clinical imaging modalities. Second, image-
based design techniques allow the creation of multiple
datasets at different resolutions. This makes it possible
to design the external anatomical shape of the scaffold
from a patient image on a centimetre scale, and the
scaffold porous architecture based on mechanical and
mass transport requirements on a sub-µm scale. The major
limitation is computer memory, becoming more readily
available all the time, and the scale at which biomaterials
can be fabricated (14,21).
There are a number of discrete advantages of SLS in
comparison to the other forms of SFF and conventional
fabrication techniques. Complex geometries can be
manufactured using the layered technique, due to the
ability of the laser to access the internal structures in
a step-wise fashion. With this method, the surrounding
loose powder supports the sintered scaffold, allowing for
the creation of overhangs and rapidly changing cross-
sections. The desired scaffold design is gradually created,
and can be removed en bloc from the surrounding loose
powder once complete (9).
Micro-CT is well known to be a non-invasive, non-
destructive technique which enables one to both analyse
and quantify scaffolds pre-operatively and regenerated
tissues post-surgically (56). The materials and specimens
can therefore be used for future destructive analysis,
including histology. More specifically, micro-CT can
evaluate scaffold design, architecture continuity and
connectivity, bone volume, anisotropy, tissue mineral
density and content (31,38,56–59) and, most recently,
cartilaginous tissues can be identified (60). For cartilage
analysis, the specimen must be directly subjected to
ionic contrast (Hexabrix 320, Mallinckrodt, Hazelwood,
MO, USA), which binds to sulphated glycosaminoglycans
(sGAGs), and determines the density of sGAGs based on
Figure 13. (A) Cartilaginous tissue formation can be identified with safranin O staining. Scaffold void highlighted by arrows. Inset
(B) demonstrates normal architecture of the regenerated cartilage
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attenuation. Following this method, the contrast agent can
be easily desorbed from the tissue, making the specimens
available for histological analysis (60).
Maxillofacial surgeons have a very difficult time
attempting to reconstruct osseous tissues to recapitulate
facial esthetics. The TMJ proves to be one of the most
difficult structures to reconstruct, due to its complex
geometrical shape and mechanical function, the presence
of both osseous and cartilaginous tissues in close
proximity to a fibrocartilagenous disc, and risk of ankylosis
(2). Given the demonstrated growth potential of the TMJ
of young Yucatan minipigs, we are currently applying
both a shell and an architecture-based CRU into the
mandibles of mature minipigs that have restricted growth
of their osseous tissues. We are continuing to evaluate and
apply various scaffolds fabricated through image-based
computer-aided design and SLS techniques in animal
models. Tissue engineering is proving to be a potentially
beneficial avenue to minimize the need for donor site
morbidity and also to aid in promoting the growth of hard
and soft tissues.
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